Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02108483 · ClinicalTrials.gov registry record · Phase 1
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
A Phase 1 study, sponsored by Almirall, S.A..
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT02108483 is a Phase 1 study that has completed, run by Almirall, S.A.. The registered enrollment target is 33 participants.
The verdict
NCT02108483, a Phase 1 study, has completed, sponsored by Almirall, S.A..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
This study will evaluate the potential of dapsone gel and its vehicle to cause a phototoxic reaction following irradiation of the skin under controlled conditions.
Interventions
- DRUG dapsone gel
- DRUG dapsone gel vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2014-04 |
| Est. Completion | 2014-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02108483
The ClinicalTrials.gov registry entry for NCT02108483 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Almirall, S.A., which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which dapsone gel is the first listed.
NCT02108483 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02108483 about?
NCT02108483 is a clinical study titled "Phototoxicity Test of Dapsone Gel in Healthy Volunteers". This study will evaluate the potential of dapsone gel and its vehicle to cause a phototoxic reaction following irradiation of the skin under controlled conditions.
What is the current status of trial NCT02108483?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2014-04. Estimated completion is 2014-05.
What interventions are being tested in trial NCT02108483?
The interventions under investigation include: dapsone gel (DRUG), dapsone gel vehicle (DRUG).
Who is sponsoring clinical trial NCT02108483?
This trial is sponsored by Almirall, S.A., which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.